Correction: Brivanib Attenuates Hepatic Fibrosis In Vivo and Stellate Cell Activation In Vitro by Inhibition of FGF, VEGF and PDGF Signaling.
作者信息
Nakamura Ikuo, Zakharia Kais, Banini Bubu A, Mikhail Dalia S, Kim Tae Hyo, Yang Ju Dong, Moser Catherine D, Shaleh Hassan M, Thornburgh Sarah R, Walters Ian, Roberts Lewis R
出版信息
PLoS One. 2015 Nov 3;10(11):e0142355. doi: 10.1371/journal.pone.0142355. eCollection 2015.
Abstract
摘要
相似文献
1
Correction: Brivanib Attenuates Hepatic Fibrosis In Vivo and Stellate Cell Activation In Vitro by Inhibition of FGF, VEGF and PDGF Signaling.更正：布立尼布通过抑制成纤维细胞生长因子（FGF）、血管内皮生长因子（VEGF）和血小板衍生生长因子（PDGF）信号通路，在体内减轻肝纤维化并在体外抑制星状细胞活化。
PLoS One. 2015 Nov 3;10(11):e0142355. doi: 10.1371/journal.pone.0142355. eCollection 2015.
2
Beneficial effects of dual vascular endothelial growth factor receptor/fibroblast growth factor receptor inhibitor brivanib alaninate in cirrhotic portal hypertensive rats.双血管内皮生长因子受体/成纤维细胞生长因子受体抑制剂布立尼布丙氨酸在肝硬化门脉高压大鼠中的有益作用。
J Gastroenterol Hepatol. 2014 May;29(5):1073-82. doi: 10.1111/jgh.12480.
3
Fibroblast growth factor 21 attenuates hepatic fibrogenesis through TGF-β/smad2/3 and NF-κB signaling pathways.成纤维细胞生长因子21通过TGF-β/smad2/3和NF-κB信号通路减轻肝纤维化。
Toxicol Appl Pharmacol. 2016 Jan 1;290:43-53. doi: 10.1016/j.taap.2015.11.012. Epub 2015 Nov 22.
4
Platelet-derived growth factor receptor tyrosine kinase inhibitor AG1295 attenuates rat hepatic stellate cell growth.血小板衍生生长因子受体酪氨酸激酶抑制剂AG1295可减弱大鼠肝星状细胞的生长。
J Lab Clin Med. 2000 May;135(5):406-12. doi: 10.1067/mlc.2000.105974.
5
Brivanib alaninate, a dual inhibitor of vascular endothelial growth factor receptor and fibroblast growth factor receptor tyrosine kinases, induces growth inhibition in mouse models of human hepatocellular carcinoma.丙氨酸布立尼布，一种血管内皮生长因子受体和成纤维细胞生长因子受体酪氨酸激酶的双重抑制剂，在人肝细胞癌小鼠模型中可诱导生长抑制。
Clin Cancer Res. 2008 Oct 1;14(19):6146-53. doi: 10.1158/1078-0432.CCR-08-0509.
6
VEGF-A and FGF-2 synergistically promote neoangiogenesis through enhancement of endogenous PDGF-B-PDGFRbeta signaling.血管内皮生长因子-A（VEGF-A）和成纤维细胞生长因子-2（FGF-2）通过增强内源性血小板源性生长因子-B（PDGF-B）-血小板源性生长因子受体β（PDGFRβ）信号传导协同促进新生血管形成。
J Cell Sci. 2005 Aug 15;118(Pt 16):3759-68. doi: 10.1242/jcs.02483.
7
Hesperetin derivative-7 inhibits PDGF-BB-induced hepatic stellate cell activation and proliferation by targeting Wnt/β-catenin pathway.橙皮素衍生物-7通过靶向Wnt/β-连环蛋白通路抑制血小板衍生生长因子-BB诱导的肝星状细胞活化和增殖。
Int Immunopharmacol. 2015 Apr;25(2):311-20. doi: 10.1016/j.intimp.2015.02.009. Epub 2015 Feb 17.
8
TRPM7 channel regulates PDGF-BB-induced proliferation of hepatic stellate cells via PI3K and ERK pathways.瞬时受体电位阳离子通道 7 型（TRPM7）通过 PI3K 和 ERK 通路调节血小板衍生生长因子-BB（PDGF-BB）诱导的肝星状细胞增殖。
Toxicol Appl Pharmacol. 2013 Nov 1;272(3):713-25. doi: 10.1016/j.taap.2013.08.009. Epub 2013 Aug 16.
9
Fluorofenidone attenuates hepatic fibrosis by suppressing the proliferation and activation of hepatic stellate cells.氟苯尼考通过抑制肝星状细胞的增殖和活化来减轻肝纤维化。
Am J Physiol Gastrointest Liver Physiol. 2014 Feb;306(3):G253-63. doi: 10.1152/ajpgi.00471.2012. Epub 2013 Dec 12.
10
Depletion of β-arrestin2 in hepatic stellate cells reduces cell proliferation via ERK pathway.肝星状细胞中β-arrestin2 的耗竭通过 ERK 通路减少细胞增殖。
J Cell Biochem. 2013 May;114(5):1153-62. doi: 10.1002/jcb.24458.
引用本文的文献
1
Angiogenesis and Hepatic Fibrosis: Western and Chinese Medicine Therapies on the Road.血管生成与肝纤维化：中西医结合的治疗之路
Chin J Integr Med. 2018 Sep;24(9):713-720. doi: 10.1007/s11655-018-3007-1. Epub 2018 Jun 25.
本文引用的文献
1
Brivanib attenuates hepatic fibrosis in vivo and stellate cell activation in vitro by inhibition of FGF, VEGF and PDGF signaling.布立尼布通过抑制成纤维细胞生长因子（FGF）、血管内皮生长因子（VEGF）和血小板衍生生长因子（PDGF）信号传导，在体内减轻肝纤维化，并在体外抑制星状细胞活化。
PLoS One. 2014 Apr 7;9(4):e92273. doi: 10.1371/journal.pone.0092273. eCollection 2014.
Zotero 插件